Patents by Inventor J. van der Louw

J. van der Louw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of new etonogestrel esters
    Publication number: 20050222114
    Abstract: The subject invention provides a contraceptive and/or HRT kit comprising a contraceptively and/or therapeutically effective amount of a long-acting etonogestrel ester with a fatty-chain length of C7-C15.
    Type: Application
    Filed: May 22, 2003
    Publication date: October 6, 2005
    Inventors: Henrik De Nijs, H. A. A. Van Der Voort, Dirk Leysen, A. J. Grootenhuis, J. Van Der louw
  • 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
    Patent number: 6528501
    Abstract: The invention relates to 22S hydroxycholesta-8, 14-diene derivatives having general formula (I) wherein R1 is OR, OSO3H or —NOR; with R being H, (C1-6)alkyl or (C1-6)acyl; each of R2 and R3 is independently hydrogen or (C1-6)alkyl; R4 is hydrogen, (C1-6)alkyl or (C1-6)acyl; R5 is hydrogen; or R5 designates, together with R6, an additional bond between the carbon atoms at which R5 and R6 are placed; R6 is hydrogen, hydroxy or halogen, or R6 designates, together with R5, an additional bond between the carbon atoms at which R6 and R5 are placed; each or R7 and R8 is independently hydrogen or (C1-4)alkyl, optionally substituted with OH, (C1-4)alkoxy, or halogen; or a pharmaceutically acceptable salt thereof. The compounds of the invention have meiosis activating activity and can be used for the control of fertility.
    Type: Grant
    Filed: July 16, 2001
    Date of Patent: March 4, 2003
    Assignee: Akzo Nobel N.V.
    Inventors: Dirk D. Leysen, Jaap J. van der Louw, Robert Gerard Jules Marie Hanssen, A. Anja Wiersma
  • 22R-hydroxycholesta-8, 14-diene derivatives for the inhibition of meiosis
    Patent number: 6518262
    Abstract: The invention relates to 22R-hydroxycholesta-8,14-diene derivatives having general formula (I) wherein R1 is OR, OS03H or ═NOR; with R being H, (C1-6)alkyl or (C1-6)acyl; each of R2 and R3 is independently hydrogen or (C1-6)alkyl; R4 is hydrogen, (C1-6)alkyl or (C1-6)acyl; R5 is hydrogen; or R5 designates, together with R6, an additional bond between the carbon atoms at which R5 and R6 are placed; R6 is hydrogen, hydroxy or halogen; or R6 designates, together with R5, an additional bond between the carbon atoms at which R6 and R5 are placed; each of R7 and R8 is independently hydrogen or (C1-4)alkyl, optionally substituted with OH, (C1-4)alkoxy, or halogen; or a pharmaceutically acceptable salt thereof. The compounds of the invention have meiosis inhibiting activity and can be used for the control of fertility.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: February 11, 2003
    Assignee: Akzo Nobel N.V.
    Inventors: D. Leysen, J. van der Louw, R. G. J. M. Hanssen, Anja Wiersma